Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Apiam Animal Health Ltd. ( (AU:AHX) ) just unveiled an announcement.
Apiam Animal Health Limited announced that the Foreign Investment Review Board condition for its proposed acquisition by Adamantem Capital’s entities, Pepper Bidco Pty Ltd and Pepper Holdco Limited, via a scheme of arrangement has been satisfied, after the Commonwealth Government confirmed it has no objections to the deal. The transaction now hinges on Apiam shareholder approval at a Scheme Meeting on 3 February 2026 in Melbourne and online, as well as final Court approval and remaining conditions, marking a key step toward a potential change of ownership that could reshape the company’s capital structure and strategic direction.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Limited is one of Australia’s leading rural veterinary businesses, operating more than 80 veterinary clinic sites and ancillary business locations nationwide. Employing over 1,000 staff, including a large team of experienced veterinarians, the company provides veterinary, production animal and allied services across regional towns and fast-growing peri-urban areas, focusing on best-in-class animal care and community support.
Average Trading Volume: 397,003
Technical Sentiment Signal: Buy
Current Market Cap: A$160.1M
For a thorough assessment of AHX stock, go to TipRanks’ Stock Analysis page.

